Houston energy exec named to statewide position

mover and shaker

Vicki Hollub has been appointed chairwoman of the Texas Economic Development Corp. Photo via Oxy

Vicki Hollub, president and CEO of Houston-based oil and gas company Occidental Petroleum, has been appointed chairwoman of the Texas Economic Development Corp.

Hollub, who lives in Galveston, had been vice chairwoman of TxEDC, a privately funded nonprofit that collaborates with the state-funded Governor’s Office of Economic Development and Tourism to promote Texas as a business location. She succeeds Temple businessman Drayton McLane Jr., former owner of the Houston Astros, as chair of the Austin-based organization.

Hollub became the first woman to lead a major American oil and gas company when she was tapped as Occidental’s president and CEO in 2016. She has worked at Occidental for 35 years.

In a 2020 interview, Hollub outlined Occidental’s future as a “carbon management company.”

“Ultimately, I don’t know how many years from now, Occidental becomes a carbon management company, and our oil and gas would be a support business unit for the management of that carbon. We would be not only using [CO2] in oil reservoirs [but] capturing it for sequestration as well,” Hollub said.

Aside from elevating Hollub to the role of chairwoman, Gov. Greg Abbott has named Houston’s Mauricio Gutierrez to the TxEDC board of directors. Gutierrez is president and CEO of Houston-based NRG Energy.

Abbott’s office also made two other recent business-related announcements involving the Houston area:

  • Workforce development grants from the Texas Talent Connection program were awarded to Alvin Community College, the Bay Area Houston Advanced Technology Consortium, Capital IDEA of Houston, Lone Star College, the University of Houston – Downtown, and Volunteers of America.
  • Grants for science, technology, engineering, and math (STEM) summer youth camps were awarded to Lone Star College – Tomball, the University of Houston – Clear Lake, Brazosport College, the San Jacinto Community College District, and Houston Community College.
Oxy is working on a direct air carbon capture facility in the Permian Basin — and is committing to up to a $1 billion price tag for the project. Rendering via 1pointfive.com

Houston oil and gas company reveals details on $1B carbon capture facility

seeing green

Ramping up its investment in clean energy, Houston-based Occidental Petroleum plans to spend up to $1 billion on a facility in the Permian Basin that will pull carbon dioxide from the air.

During a March 23 investor update, executives at Occidental laid out their strategy for developing direct air carbon capture plants and carbon sequestration hubs.

Executives said Occidental’s first direct air capture facility is set to be built in the Permian Basin, a massive oil-producing region in West Texas and southeastern New Mexico. The industrial-scale facility, with an estimated price tag of $800 million to $1 billion, is on track to open in late 2024. Construction is supposed to start later this year.

Occidental expects as many as 135 of its direct air carbon capture plants to be operating by 2035.

According to the International Energy Agency, direct air capture (DAC) technologies extract carbon dioxide, or CO2, directly from the atmosphere. The CO2 can be permanently stored in deep geological formations, or it can be used in food processing or can be combined with hydrogen to produce synthetic fuels.

As of November, 19 DAC facilities were operating around the world, according to the energy agency. Occidental envisions the Permian Basin plant pulling 1 million metric tons of CO2 from the air each year — an amount that would far exceed the combined capacity of the 19 facilities that already are online.

Aside from DAC facilities, Occidental plans to put three carbon sequestration hubs online by 2025. These hubs take carbon dioxide from the air and several other sources, such as factories and power plants, and then transport and store it using shared infrastructure, the Oil and Gas Climate Initiative explains.

Beyond the three locations already accounted for, several more Occidental sequestration hubs are in the works. Some of those sites will be in the Gulf Coast region.

During the investor presentation, Occidental President and CEO Vicki Hollub reiterated that she believes the company’s 1PointFive carbon capture initiative will ultimately create more value than its petrochemical business. The petrochemical unit generated $5.2 billion in revenue last year.

Hollub called carbon capture “a sure opportunity” for Occidental.

“There’s just not going to be enough other alternatives for CO2 offsets for corporate America and … corporations around the world,” Hollub said.

Occidental already is gaining value from DAC. For instance, aircraft manufacturer Airbus recently said it would buy 400,000 metric tons of carbon removal credits from Occidental’s first DAC facility over a four-year span.

Occidental is among numerous companies — including Houston energy heavyweights BP, ExxonMobil, and Shell — seeking to capitalize on the carbon capture and sequestration market. Fortune Business Insights forecasts the value of the global market will grow from $2 billion in 2021 to $7 billion by 2028.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.

View All Listings